ARCHIVES

NSABP Disputed NCI Cost Estimate For P-4 Trial.

This article is from The Cancer Letter archive.

Vol. 33 No. 20 | May 25, 2007

Download PDF Visit The Full Archive

Related Articles

The Impact of Triple Calamities: Flat Funding, the End of ARRA, and a Dramatic Loss of Purchasing Power

October 31, 2014

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Cytopathologists, NCI Recommend New Method For Pap Smear Reports

August 25, 1989

New NCI Shakeup: O’Connor Leave DCCP to return To International Office; Adamson Acting Director

September 12, 1980

Society Support Program for Training Cytotechnologists

November 29, 1991

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976